ArticleOncotarget2024

Correction: The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation.

Christophe Le Clorennec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.